Sera Prognostics, Inc. Profile Avatar - Palmy Investing

Sera Prognostics, Inc.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous prete…

Medical - Diagnostics & Research
US, Salt Lake City [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SERA's Analysis
CIK: 1534969 CUSIP: 81749D107 ISIN: US81749D1072 LEI: - UEI: -
Secondary Listings
SERA has no secondary listings inside our databases.